CTI BioPharma (NASDAQ: CTIC) is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. In particular, we are focused on evaluating pacritinib, our sole product candidate currently in active late-stage development, for the treatment of adult patients with myelofibrosis. Pacritinib is also being investigated in acute graft versus host disease (GvHD) in an ongoing investigator-sponsored Phase 1/2 study. We are headquartered in Seattle, Washington.
Location: United States, Washington, Seattle
Employees: 201-500
Founded date: 1992
Investors 3
| Date | Name | Website |
| 07.08.2021 | New Enterp... | nea.com |
| - | Hercules C... | htgc.com |
| - | Ignite 500 | ignite500.... |
Mentions in press and media 28
| Date | Title | Description | Source |
| 20.11.2023 | Sobi to present new data at ASH 2023 Annual Meeting | Sobi to present new data at ASH 2023 Annual Meeting Mon, Nov 20, 2023 08:00 CET Report this content... | news.cisio... |
| 25.05.2023 | Sobi commences tender offer for all outstanding shares of co... | Sobi commences tender offer for all outstanding shares of common stock of CTI BioPharma Corp. Thu, ... | news.cisio... |
| 10.05.2023 | Sobi to acquire CTI BioPharma Corp. enhancing Sobi’s positio... | Sobi to acquire CTI BioPharma Corp. enhancing Sobi’s position in rare haematology Wed, May 10, 2023... | news.cisio... |
| 10.05.2023 | Sobi to Acquire CTI BioPharma, for Approx. $1.7 Billion | Swedish Orphan Biovitrum AB (STO: SOBI) (“Sobi”), a global healthcare leader in hematology, immunolo... | finsmes.co... |
| 08.09.2021 | CTI BioPharma Announces Inducement Grants Under Nasdaq Listi... | SEATTLE, Sept. 8, 2021 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an ... | prnewswire... |
| 26.08.2021 | CTI BioPharma Announces Inducement Grants Under Nasdaq Listi... | SEATTLE, Aug. 26, 2021 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an ... | prnewswire... |
| 24.08.2021 | CTI BioPharma Announces Appointment of Diane Parks to Its Bo... | SEATTLE, Aug. 24, 2021 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced the appo... | prnewswire... |
| 26.07.2021 | CTI BioPharma Announces Inducement Grants Under Nasdaq Listi... | SEATTLE, July 26, 2021 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an ... | prnewswire... |
| 09.07.2021 | CTI BioPharma Announces Inducement Grants Under Nasdaq Listi... | SEATTLE, July 8, 2021 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an a... | prnewswire... |
| 23.06.2021 | CTI BioPharma Announces Inducement Grants Under Nasdaq Listi... | SEATTLE, June 23, 2021 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that the... | prnewswire... |
Show more